Literature DB >> 16631415

Health care resource utilization in inflammatory bowel disease.

Teresa Longobardi1, Charles N Bernstein.   

Abstract

BACKGROUND & AIMS: The aim of this study was to quantify temporal changes in health care utilization by a population-based cohort of IBD.
METHODS: By using the University of Manitoba IBD Epidemiology Database we assessed utilization of outpatient and hospital services, estimating relative risk (RR) of utilization for IBD cases compared with a matched cohort of non-IBD controls and for CD versus UC. We tested differences in utilization between prevalence cohorts 1990-1991 and 2000-2001. Also, utilization of the 1987-1988 incidence cohort was followed forward 15 years from diagnosis. The probability, intensity, and volume of utilization were estimated.
RESULTS: In 2000-2001, IBD patients compared with controls were more likely to have an outpatient visit (RR, 1.18; 95% confidence interval [CI], 1.17-1.19) and an overnight hospital stay (RR, 2.32; 95% CI, 2.16-2.49). CD cases were more likely than UC cases to be hospitalized (RR, 1.26; 95% CI, 1.11-1.43) and had a greater number of outpatient visits. From 1990-1991 to 2000-2001, IBD cases experienced a significant decrease in the likelihood of an outpatient surgical visit relative to non-IBD controls (P < .05), and for those cases who were hospitalized, CD cases tended to be less likely than UC cases to experience IBD-specific inpatient surgery (P < .07). Of the 1987-1988 incidence cohort, 80% of admissions that occurred during the follow-up period were during the first 5 years after diagnosis.
CONCLUSIONS: In 2000-2001, health care utilization continued to be higher in IBD versus controls and CD versus UC; however, the gap in costly service utilization appeared to narrow between the latter pair.

Entities:  

Mesh:

Year:  2006        PMID: 16631415     DOI: 10.1016/j.cgh.2006.02.013

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  19 in total

1.  Comorbidity increases the risk of hospitalizations in multiple sclerosis.

Authors:  Ruth Ann Marrie; Lawrence Elliott; James Marriott; Michael Cossoy; Aruni Tennakoon; Nancy Yu
Journal:  Neurology       Date:  2014-12-24       Impact factor: 9.910

Review 2.  Inflammatory bowel disease: a Canadian burden of illness review.

Authors:  Angela Rocchi; Eric I Benchimol; Charles N Bernstein; Alain Bitton; Brian Feagan; Remo Panaccione; Kevin W Glasgow; Aida Fernandes; Subrata Ghosh
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

3.  Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012.

Authors:  Petra A Golovics; Laszlo Lakatos; Michael D Mandel; Barbara D Lovasz; Zsuzsanna Vegh; Zsuzsanna Kurti; Istvan Szita; Lajos S Kiss; Tunde Pandur; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

4.  Prevalence and incidence of antimicrobial-resistant organisms among hospitalized inflammatory bowel disease patients.

Authors:  Alon Vaisman; Kevin Pivovarov; Allison McGeer; Barbara Willey; Bjug Borgundvaag; Vanessa Porter; Piraveina Gnanasuntharam; Yanliang Wei; Geoffrey C Nguyen
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

5.  Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease.

Authors:  Michael D Kappelman; Carol Q Porter; Joseph A Galanko; Sheryl L Rifas-Shiman; Daniel A Ollendorf; Robert S Sandler; Jonathan A Finkelstein
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

6.  Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity.

Authors:  Manie Juneja; Leonard Baidoo; Marc B Schwartz; Arthur Barrie; Miguel Regueiro; Michael Dunn; David G Binion
Journal:  Dig Dis Sci       Date:  2012-02-23       Impact factor: 3.199

7.  Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.

Authors:  Thomas Cars; Björn Wettermark; Robert Löfberg; Irene Eriksson; Johan Sundström; Mikael Lördal
Journal:  J Crohns Colitis       Date:  2016-01-05       Impact factor: 9.071

8.  Dramatically changing rates and reasons for hospitalization in multiple sclerosis.

Authors:  Ruth Ann Marrie; Lawrence Elliott; James Marriott; Michael Cossoy; James Blanchard; Aruni Tennakoon; Nancy Yu
Journal:  Neurology       Date:  2014-08-01       Impact factor: 9.910

9.  Drivers of cost after surgical and medical therapy for chronic ulcerative colitis: a nested case-cohort study in Olmsted County, Minnesota.

Authors:  Stefan D Holubar; Rajesh Pendlimari; Edward V Loftus; James P Moriarty; Dirk Larson; Megan O'Byrne; John H Pemberton; Robert R Cima
Journal:  Dis Colon Rectum       Date:  2012-12       Impact factor: 4.585

10.  Cost-effectiveness of Crohn's disease post-operative care.

Authors:  Emily K Wright; Michael A Kamm; Peter Dr Cruz; Amy L Hamilton; Kathryn J Ritchie; Sally J Bell; Steven J Brown; William R Connell; Paul V Desmond; Danny Liew
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.